Rhythm Pharmaceuticals, Inc. SEC filings RYTM

Rhythm Pharmaceuticals, Inc. has 837 filings in SEC EDGAR's recent list, going back to Aug 12, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Rhythm Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 4, 2026 Aug 4, 2026
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 24, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 15, 2026 Jun 13, 2026
DEFA14A Additional proxy material May 29, 2026 —
S-8 Employee stock plan registration May 5, 2026 —
DEFA14A Additional proxy material May 5, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 29, 2026 Jun 24, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 3, 2026 Apr 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 26, 2026 Mar 26, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 20, 2026 Mar 19, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 16, 2026 Mar 16, 2026
8-K Current report
Regulation FD disclosure, Other events
Mar 2, 2026 Mar 2, 2026
S-3ASR Automatic shelf registration Feb 26, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
S-8 Employee stock plan registration Jan 16, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 9, 2026 Jan 9, 2026
8-K Current report
Officer or director change
Dec 19, 2025 Dec 16, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 11, 2025 Dec 11, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 7, 2025 Nov 6, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Other events
Jul 11, 2025 Jul 9, 2025
424B5 Prospectus supplement Jul 10, 2025 —
424B5 Prospectus supplement Jul 9, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jul 9, 2025 Jul 9, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 26, 2025 Jun 24, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
PRE 14A Preliminary proxy statement Apr 18, 2025 Jun 24, 2025
8-K Current report
Regulation FD disclosure, Other events
Apr 7, 2025 Apr 7, 2025
8-K Current report
Agreement ended, Regulation FD disclosure
Mar 20, 2025 Mar 14, 2025
S-8 Employee stock plan registration Feb 28, 2025 —
8-K Current report
Other events
Feb 28, 2025 Feb 27, 2025
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 10, 2025 Jan 10, 2025
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
8-K Current report
Shareholder vote results
Sep 19, 2024 Sep 18, 2024
10-Q/A Amended quarterly report Aug 14, 2024 Jun 30, 2024
DEFA14A Additional proxy material Aug 7, 2024 —
DEFR14A Filing Aug 7, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
8-K Current report
Other events
Jul 10, 2024 Jul 10, 2024
424B7 Filing Jul 10, 2024 —
DEFA14A Additional proxy material Jun 17, 2024 —
8-K Current report
Other events
Jun 17, 2024 Jun 17, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 18, 2024
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 16, 2024 Apr 15, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 1, 2024 Apr 1, 2024
S-8 Employee stock plan registration Feb 29, 2024 —
8-K Current report
Material agreement
Feb 29, 2024 Feb 29, 2024
424B5 Prospectus supplement Feb 29, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations, Other events
Feb 22, 2024 Feb 22, 2024
8-K Current report
Regulation FD disclosure
Jan 4, 2024 Jan 4, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 4, 2024 Jan 4, 2024
8-K Current report
Bylaw or fiscal year change
Dec 18, 2023 Dec 14, 2023
8-K Current report
Other events
Dec 6, 2023 Dec 6, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Aug 21, 2023 Aug 21, 2023
8-K Current report
Officer or director change
Aug 8, 2023 Aug 4, 2023
8-K Current report
Officer or director change
Aug 3, 2023 Jul 28, 2023
10-Q Quarterly report Aug 1, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 1, 2023 Aug 1, 2023
8-K Current report
Shareholder vote results
Jun 22, 2023 Jun 21, 2023
10-Q Quarterly report May 2, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 2, 2023 May 2, 2023
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 21, 2023
ARS Annual report to shareholders Apr 27, 2023 Dec 31, 2022
8-K Current report
Other events
Mar 10, 2023 Mar 10, 2023
S-3ASR Automatic shelf registration Mar 2, 2023 —
S-8 Employee stock plan registration Mar 2, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 1, 2023 Mar 1, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Agreement ended
Nov 3, 2022 Oct 28, 2022
8-K Current report
Other events
Sep 15, 2022 Sep 14, 2022
424B5 Prospectus supplement Sep 15, 2022 —
424B5 Prospectus supplement Sep 14, 2022 —
10-Q Quarterly report Aug 3, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 2, 2022 Aug 2, 2022
8-K Current report
Material agreement, New debt
Jun 16, 2022 Jun 16, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 8, 2022
10-Q Quarterly report May 3, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 3, 2022 May 3, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 8, 2022
8-K Current report
Regulation FD disclosure
Apr 6, 2022 Apr 6, 2022
S-8 Employee stock plan registration Mar 1, 2022 —
S-8 Employee stock plan registration Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
8-K Current report
Material agreement
Dec 8, 2021 Dec 3, 2021
EFFECT Filing Nov 15, 2021 —
CORRESP Letter to the SEC Nov 10, 2021 —
UPLOAD Letter from the SEC Nov 9, 2021 —
S-3 Shelf registration Nov 2, 2021 —
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 2, 2021 Nov 2, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 2, 2021 Aug 31, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 3, 2021 Aug 3, 2021
8-K Current report
Shareholder vote results
Jun 14, 2021 Jun 9, 2021
8-K Current report
Results of operations
May 3, 2021 May 3, 2021
10-Q Quarterly report May 3, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 27, 2021 —
DEF 14A Proxy statement Apr 27, 2021 Jun 9, 2021
8-K Current report
Officer or director change
Apr 23, 2021 Apr 23, 2021
8-K Current report
Officer or director change
Mar 16, 2021 Mar 11, 2021
S-8 Employee stock plan registration Mar 1, 2021 —
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
8-K Current report
Other events
Feb 5, 2021 Feb 4, 2021
424B5 Prospectus supplement Feb 5, 2021 —
424B5 Prospectus supplement Feb 3, 2021 —
8-K Current report
Results of operations, Other events
Feb 3, 2021 Feb 3, 2021
8-K Current report
Regulation FD disclosure
Feb 3, 2021 Feb 2, 2021
8-K Current report
Material agreement
Jan 5, 2021 Jan 5, 2021
8-K/A Amended current report
Officer or director change
Jan 4, 2021 Dec 31, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 11, 2020 Dec 9, 2020
10-Q Quarterly report Nov 2, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 2, 2020 Nov 2, 2020
8-K Current report
Officer or director change, Other events
Sep 16, 2020 Sep 14, 2020
CT ORDER Filing Aug 17, 2020 —
10-Q Quarterly report Aug 3, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 3, 2020 Aug 3, 2020
8-K Current report
Material agreement, Officer or director change
Jul 21, 2020 Jul 15, 2020
8-K Current report
Shareholder vote results
Jun 18, 2020 Jun 17, 2020
10-Q Quarterly report May 4, 2020 Mar 31, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 17, 2020
8-K Current report
Officer or director change
Mar 30, 2020 Mar 27, 2020
8-K Current report
Results of operations
Mar 2, 2020 Mar 2, 2020
S-8 Employee stock plan registration Mar 2, 2020 —
10-K Annual report Mar 2, 2020 Dec 31, 2019
8-K Current report
Material agreement
Feb 26, 2020 Feb 20, 2020
8-K Current report
Regulation FD disclosure
Jan 10, 2020 Jan 10, 2020
8-K Current report
Officer or director change
Jan 8, 2020 Jan 6, 2020
8-K Current report
Regulation FD disclosure
Nov 6, 2019 Nov 4, 2019
8-K Current report
Results of operations
Nov 1, 2019 Nov 1, 2019
10-Q Quarterly report Nov 1, 2019 Sep 30, 2019
8-K Current report
Other events
Oct 16, 2019 Oct 15, 2019
424B5 Prospectus supplement Oct 16, 2019 —
8-K Current report
Results of operations
Oct 15, 2019 Oct 15, 2019
424B5 Prospectus supplement Oct 15, 2019 —
8-K Current report
Regulation FD disclosure
Sep 25, 2019 Sep 25, 2019
8-K Current report
Other events
Aug 7, 2019 Aug 7, 2019
8-K Current report
Regulation FD disclosure
Jul 29, 2019 Jul 29, 2019
8-K Current report
Results of operations
Jul 29, 2019 Jul 29, 2019
10-Q Quarterly report Jul 29, 2019 Jun 30, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 25, 2019 Jul 23, 2019
8-K Current report
Shareholder vote results
Jun 21, 2019 Jun 19, 2019
8-K Current report
Officer or director change
May 23, 2019 May 19, 2019
8-K Current report
Results of operations
May 3, 2019 May 3, 2019
10-Q Quarterly report May 3, 2019 Mar 31, 2019
DEF 14A Proxy statement Apr 30, 2019 Jun 19, 2019
8-K Current report
Regulation FD disclosure
Mar 28, 2019 Mar 28, 2019
8-K Current report
Results of operations
Mar 8, 2019 Mar 8, 2019
10-K Annual report Mar 8, 2019 Dec 31, 2018
S-8 Employee stock plan registration Feb 13, 2019 —
8-K Current report
Regulation FD disclosure
Jan 8, 2019 Jan 4, 2019
S-3ASR Automatic shelf registration Nov 9, 2018 —
8-K Current report
Other events
Nov 9, 2018 Nov 9, 2018
8-K Current report
Results of operations
Nov 9, 2018 Nov 9, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
8-K Current report
Material agreement, Results of operations
Aug 9, 2018 Aug 6, 2018
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
424B4 Prospectus Jun 21, 2018 —
EFFECT Filing Jun 20, 2018 —
S-1MEF Filing Jun 20, 2018 —
S-1/A Amended registration statement Jun 20, 2018 —
CORRESP Letter to the SEC Jun 18, 2018 —
CORRESP Letter to the SEC Jun 18, 2018 —
S-1 Registration statement Jun 18, 2018 —
UPLOAD Letter from the SEC Jun 18, 2018 —
8-K Current report
Shareholder vote results
Jun 11, 2018 Jun 6, 2018
DRS Filing Jun 11, 2018 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RYTM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Large accelerated filer
SEC CIK
1649904
Former names
RHYTHM METABOLIC, INC. (until Aug 12, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.